FDA Approved: CORDRAN — Supplemental Application (INA Pharmaceutics, Inc)

View source ↗

Summary

The FDA approved a supplemental application for Cordran (flurandrenolide) from INA Pharmaceutics, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Contact Dermatitis
• Dermatitis

Drugs mentioned

• CORDRAN (FLURANDRENOLIDE)

Snippet

SUPPL AP for CORDRAN (FLURANDRENOLIDE)